This might be palatable if this outlay offered substantial medical outcomes in the U.S. As reported in Part One of this series Part One of this series, for some illnesses, such as cancer and stroke, mortality rates in the U.S. are better, though not dramatically so, while we rank near the bottom for diabetes and infant mortality.